| |
Death at 1-Year Post-Discharge |
|
| |
Base Model |
Demographic Adjusted Model |
Caregiving Adjusted Model |
Clinical Condition Adjusted Model |
Fully Adjusted Model |
| |
OR (95%CI) |
OR (95%CI) |
OR (95%CI) |
OR (95%CI) |
OR (95%CI) |
| Race/Ethnicity |
| Black vs. White/Asian |
0.75 (0.41, 1.37) |
0.80 (0.43, 1.50) |
0.72 (0.39, 1.32) |
0.91 (0.48, 1.73) |
1.01 (0.51, 2.00) |
| Hispanic vs. White/Asian |
0.51 (0.28, 0.94) |
0.53 (0.28, 1.00) |
0.45 (0.24, 0.84) |
0.54 (0.29, 1.03) |
0.55 (0.28, 1.10) |
| Hispanic vs. Black |
0.68 (0.32, 1.43) |
0.66 (0.31, 1.40) |
0.62 (0.29, 1.33) |
0.60 (0.27, 1.31) |
0.55 (0.24, 1.23) |
| Age ≥65 |
- |
2.03 (1.25, 3.31) |
- |
- |
2.87 (1.62, 5.09) |
| Men |
- |
1.05 (0.64, 1.74) |
- |
- |
1.30 (0.75, 2.25) |
| Medicaid vs. Other/No Health Insurance Type |
- |
1.37 (0.72, 2.63) |
- |
- |
1.45 (0.71, 2.93) |
| Paid Caregiver Prior to Admit or Post Discharge vs. None |
- |
- |
2.11 (1.28, 3.49) |
- |
2.00 (1.14, 3.51) |
| Ischemic Heart Failure |
- |
- |
- |
1.39 (0.79, 2.43) |
1.25 (0.70, 2.24) |
| Hypertension |
- |
- |
- |
1.05 (0.61, 1.78) |
0.88 (0.50, 1.54) |
| Diabetes |
- |
- |
- |
1.16 (0.67, 2.02) |
1.09 (0.61, 1.94) |
| Renal Failure/Dialysis |
- |
- |
- |
0.86 (0.50, 1.48) |
0.72 (0.41, 1.27) |
| Peripheral Vascular Disease |
- |
- |
- |
1.41 (0.68, 2.91) |
1.41 (0.66, 2.98) |
| Inotrope |
- |
- |
- |
1.43 (0.82, 2.51) |
1.67 (0.94, 3.00) |
| Statin |
- |
- |
- |
0.76 (0.44, 1.33) |
0.62 (0.35, 1.11) |
| Ace/ARB |
- |
- |
- |
0.41 (0.24, 0.69) |
0.42 (0.24, 0.73) |
| Beta Blocker |
- |
- |
- |
0.48 (0.27, 0.85) |
0.43 (0.24, 0.78) |
| Calcium ChannelBlocker |
- |
- |
- |
0.42 (0.18, 0.97) |
0.33 (0.14, 0.79) |
| Diuretic |
- |
- |
- |
1.30 (0.68, 2.45) |
1.44 (0.74, 2.81) |
|
